Corporate / M&A

IP / IT

Windward Bio_we_640x140

Homburger News

Share-Image Teamplate Deals-and-Cases

On January 10, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases, announced its launch with a USD 200 m series A financing from lead investors OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and co-investors SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital and Pivotal bioVenture Partners. Windward Bio has entered into an agreement to license WIN378, a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP), from Kelun-Biotech and Harbour BioMed for global rights, excepting China and select smaller markets in Asia.
Proceeds from the financing will be used to develop a phase 2-ready, long-acting anti-TSLP antibody with best-in-class potential in asthma and chronic obstructive pulmonary disease (COPD).
Homburger AG advises Windward Bio on its set-up and financing. The Homburger team comprises Andreas Müller, Margrit Marti, Oliver Kneubühl, Kaiyan Yeo, Eric Huber, Jonas Stähli, Rebecca Sigrist and Carolina Rodriguez (all Corporate / M&amp;A), Stefan Oesterhelt and Juliette Buob (both Tax) and Luca Dal Molin (IP / IT).

Homburger advises Windward Bio on its USD 200 m Series A Financing

Capital Markets

Financing and Investment Products

Real Estate

Regulatory

YODA plc_web_640x140

On December 27, 2024, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its major investment into ULTIMA CAPITAL SA (Ultima), a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA).
As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Papacamp Investments Limited (Papacamp) at a contribution value of approximately CHF 484.6 m in return for 8,076,667 newly-issued shares of Ultima. Papacamp indirectly owns real estate properties and real estate developments in Greece within the luxury hospitality sector. As a result of the transaction, Yoda has become Ultima&#8217;s largest shareholder, with a shareholding interest in Ultima of approximately 53.8%. In addition, Yoda has granted Ultima a loan in the amount of CHF 71 m.
The Homburger team advising Yoda on all aspects of the transaction was led by Stefan Blunschi and included Micha Fankhauser, Oliver Kneubühl, Jonas Stähli and Leander Etter (all Corporate / M&amp;A), Lorenzo Togni and Kaiyan Yeo (both Capital Markets), Claudia Suter, Philippe Weber and Philippe Gobet (all Tax), Stefan Bindschedler and Nathalie Scherrer (both Financing and Investment Products), Stefan Gäumann and Olivier Bühlmann (both Real Estate), and Richard Stäuber and David Thomann (both Regulatory).

Homburger advised Yoda PLC on its investment into ULTIMA CAPITAL SA

Equinix-web-640x140

Homburger advised Equinix, Inc. in connection with the issuance of CHF 100 m 1.5575% Green Bonds due in 2029

On September 4, 2024, Equinix, Inc., a globally leading digital infrastructure company, successfully completed its Swiss issuance of CHF 100 m 1.5575% Green Bonds due in 2029. The Bonds were issued by Equinix Europe 1 Financing Corporation LLC and are fully guaranteed by Equinix, Inc. The offering of the Bonds was done by reliance on Regulation S under the U.S. Securities Act. The net proceeds from the sale of the Bonds will be used to finance or refinance, in whole or in part, one or more eligible green projects of Equinix.
Homburger advised Equinix on all Swiss law aspects of the transaction. The Homburger team was led by Alexander Wherlock (Financing and Investment Products) and included Jürg Frick (Financing and Investment Products), Sofiya Shavlak and Philipp Klein (both Capital Markets), Oliver Kneubühl (Corporate / M&amp;A) as well as Stefan Oesterhelt (Tax).

Oliver
Kneubühl

Homburger advises Windward Bio on its USD 200 m Series A Financing

Homburger advised Yoda PLC on its investment into ULTIMA CAPITAL SA

Homburger advised Equinix, Inc. in connection with the issuance of CHF 100 m 1.5575% Green Bonds due in 2029

Haftungsrechtliche Folgen einer gesetzlichen Regelung der Ad hoc-Publizität

Swissair: Pflichtgemässe Verletzung von Kapitalschutzvorschriften?

Join the Team

Oliver Kneubühl

Career

Languages

Bar Registration

Teams

OliverKneubühl

Homburger advises Windward Bio on its USD 200 m Series A Financing

Homburger advised Yoda PLC on its investment into ULTIMA CAPITAL SA

Homburger advised Equinix, Inc. in connection with the issuance of CHF 100 m 1.5575% Green Bonds due in 2029

Haftungsrechtliche Folgen einer gesetzlichen Regelung der Ad hoc-Publizität

Swissair: Pflichtgemässe Verletzung von Kapitalschutzvorschriften?

Join the Team

Oliver Kneubühl

Career

Languages

Bar Registration

Teams

Oliver
Kneubühl